Grandfield & Dodd LLC bought a new position in Waters Corporation (NYSE:WAT – Free Report) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 1,839 shares of the medical instruments supplier’s stock, valued at approximately $690,000.
A number of other hedge funds and other institutional investors have also bought and sold shares of the business. BlackRock Inc. purchased a new position in shares of Waters during the second quarter valued at approximately $3,182,191,000. Dunhill Financial LLC purchased a new position in Waters during the 2nd quarter valued at about $75,000. Deutsche Bank AG bought a new stake in shares of Waters in the 2nd quarter worth approximately $156,335,000. Trust Co. of Vermont bought a new stake in Waters in the second quarter worth $2,334,000. Finally, Mitsubishi UFJ Asset Management Co. Ltd. bought a new position in Waters in the 2nd quarter worth about $89,864,000. Institutional investors own 94.01% of the company’s stock.
Waters Price Performance
WAT stock opened at $407.75 on Tuesday. The firm has a market capitalization of $40.06 billion, a P/E ratio of 101.68, a price-to-earnings-growth ratio of 2.40 and a beta of 1.19. Waters Corporation has a 52 week low of $282.77 and a 52 week high of $420.26. The company has a quick ratio of 1.29, a current ratio of 1.86 and a debt-to-equity ratio of 0.32. The company has a fifty day simple moving average of $378.07 and a two-hundred day simple moving average of $346.12.
Analyst Upgrades and Downgrades
WAT has been the topic of several analyst reports. Evercore reaffirmed an “outperform” rating and issued a $420.00 price objective on shares of Waters in a research report on Wednesday, August 5th. Piper Sandler began coverage on shares of Waters in a report on Thursday, June 11th. They issued a “neutral” rating and a $400.00 price objective on the stock. Sanford C. Bernstein started coverage on Waters in a research report on Friday, June 26th. They set an “outperform” rating and a $435.00 target price on the stock. HSBC upped their price target on shares of Waters from $415.00 to $435.00 and gave the stock a “buy” rating in a research report on Wednesday, June 3rd. Finally, Robert W. Baird set a $387.00 price objective on Waters in a research note on Wednesday, May 6th. Three investment analysts have rated the stock with a Strong Buy rating, nine have issued a Buy rating and eight have assigned a Hold rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $420.35.
Check Out Our Latest Stock Report on Waters
Insider Activity
In other news, Director Christopher A. Kuebler sold 3,626 shares of the stock in a transaction on Thursday, August 6th. The stock was sold at an average price of $397.94, for a total transaction of $1,442,930.44. Following the transaction, the director owned 17,808 shares of the company’s stock, valued at approximately $7,086,515.52. This represents a 16.92% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 0.31% of the company’s stock.
Waters Profile
Waters Corporation is a global provider of analytical instruments, software and services for laboratory and research applications. The company designs, manufactures and sells technologies centered on liquid chromatography, mass spectrometry, separation science, and related sample preparation and detection systems. Its product portfolio includes chromatographs, mass spectrometers, columns and consumables, laboratory informatics and workflow software, as well as technical support and training services that help customers run and interpret complex analyses.
Waters serves a wide range of end markets that include pharmaceutical and biotechnology companies, contract research and testing laboratories, academic and government research institutions, clinical diagnostics, food and environmental testing, and industrial and chemical manufacturers.
Featured Stories
- Five stocks we like better than Waters
- Commodities Are Booming, But These 3 ETFs Tell Different Stories
- 3 Active ETFs Making Big Moves in August
- This ETF Is Outperforming by Avoiding the S&P 500’s Biggest Problem
- Birkenstock Beats the Skeptics—But Not on EPS
Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.
